ATE530166T1 - Verfahren zum erhalt von kochleär-strukturen, impfzusammensetzungen, hilfsmittel und zwischenprodukte davon - Google Patents

Verfahren zum erhalt von kochleär-strukturen, impfzusammensetzungen, hilfsmittel und zwischenprodukte davon

Info

Publication number
ATE530166T1
ATE530166T1 AT03773445T AT03773445T ATE530166T1 AT E530166 T1 ATE530166 T1 AT E530166T1 AT 03773445 T AT03773445 T AT 03773445T AT 03773445 T AT03773445 T AT 03773445T AT E530166 T1 ATE530166 T1 AT E530166T1
Authority
AT
Austria
Prior art keywords
kochleär
additionals
obtaining
structures
intermediate products
Prior art date
Application number
AT03773445T
Other languages
English (en)
Inventor
Martin Oliver German Perez
Grando Gustavo Rafael Bracho
Gonzalez Miriam De San Juan Bosco Lastre
Gonzalez Victoriano Gustavo Sierra
Huergo Concepcion Campa
Gonzalez Nestor Mora
Morales Ramon Faustino Barbera
Campo Alonso Judith Monica Del
Ramoerez Tamara Rodroeguez
Vignier Caridad Zayas
Martoenez Danay Gil
Suarez Carlos Taboada
Original Assignee
Inst Finlay Ct De Investigacion Produccion De Vacunas Y Sueros
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Finlay Ct De Investigacion Produccion De Vacunas Y Sueros filed Critical Inst Finlay Ct De Investigacion Produccion De Vacunas Y Sueros
Application granted granted Critical
Publication of ATE530166T1 publication Critical patent/ATE530166T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/008—Leishmania antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Otolaryngology (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AT03773445T 2002-11-27 2003-11-27 Verfahren zum erhalt von kochleär-strukturen, impfzusammensetzungen, hilfsmittel und zwischenprodukte davon ATE530166T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20020292A CU23313A1 (es) 2002-11-27 2002-11-27 Mã0/00todo de obtenciã"n de estructuras cocleares. composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios
PCT/CU2003/000016 WO2004047805A1 (es) 2002-11-27 2003-11-27 Obtencion de estructuras cocleares, composiciones vacunales, adyuvantes y sus intermediarios.

Publications (1)

Publication Number Publication Date
ATE530166T1 true ATE530166T1 (de) 2011-11-15

Family

ID=40122451

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03773445T ATE530166T1 (de) 2002-11-27 2003-11-27 Verfahren zum erhalt von kochleär-strukturen, impfzusammensetzungen, hilfsmittel und zwischenprodukte davon

Country Status (13)

Country Link
US (1) US20060134134A1 (de)
EP (2) EP1602360B1 (de)
CN (1) CN1744883B (de)
AR (1) AR042237A1 (de)
AT (1) ATE530166T1 (de)
AU (1) AU2003281911A1 (de)
BR (1) BR0316687A (de)
CA (1) CA2518906A1 (de)
CU (1) CU23313A1 (de)
DK (1) DK1602360T3 (de)
ES (1) ES2376227T3 (de)
WO (1) WO2004047805A1 (de)
ZA (1) ZA200504729B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8642046B2 (en) * 2007-10-09 2014-02-04 Tufts University Cholera vaccines
CU20080215A7 (es) 2008-11-19 2012-06-21 Inst Finlay Vacunas unitemporales
WO2011027956A2 (ko) * 2009-09-04 2011-03-10 주식회사이언메딕스 그람 양성 박테리아에서 유래한 세포밖 소포체 및 이를 이용한 질병 모델
CU20100083A7 (es) 2010-05-05 2012-06-21 Inst Finlay Tolerogenos adyuvados como vacuna de malaria
CU20110202A7 (es) 2011-11-02 2013-12-27 Inst Finlay Ct De Investigación Producción De Sueros Y Vacunas Composición inmunogénica de polisacáridos planos adyuvados y las formulaciones resultantes
EP2689775A1 (de) * 2012-07-25 2014-01-29 Instituto Finlay, Centro de Investigacion-Produccion de vacunas y sueros Cochlea mit nur einem mikrobenassoziierten Molekularmuster (MAMP)
US20220378902A1 (en) * 2019-08-22 2022-12-01 Sichuan University Bacterial membrane vesicles, and separation and preparation system and method therefor

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US597572A (en) * 1898-01-18 Indicator for oil-wells
CH588887A5 (de) 1974-07-19 1977-06-15 Battelle Memorial Institute
GB1578776A (en) 1976-06-10 1980-11-12 Univ Illinois Hemoglobin liposome and method of making the same
GB2026340B (en) 1978-07-03 1982-12-22 Ash P Stabilising microvesicles
DE2848965A1 (de) 1978-11-11 1980-05-22 Behringwerke Ag Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine
US4271147A (en) 1980-01-10 1981-06-02 Behringwerke Aktiengesellschaft Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same
US4663161A (en) 1985-04-22 1987-05-05 Mannino Raphael J Liposome methods and compositions
JPH01125328A (ja) 1987-07-30 1989-05-17 Centro Natl De Biopreparados 髄膜炎菌ワクチン
WO1993014744A1 (en) * 1992-02-04 1993-08-05 Chiron Corporation Non-toxic lipid vaccine formulations
US5643574A (en) 1993-10-04 1997-07-01 Albany Medical College Protein- or peptide-cochleate vaccines and methods of immunizing using the same
US5994318A (en) * 1993-10-04 1999-11-30 Albany Medical College Cochleate delivery vehicles
US5851536A (en) 1995-11-22 1998-12-22 University Of Washington Therapeutic delivery using compounds self-assembled into high axial ratio microstructures
US5834015A (en) * 1996-09-11 1998-11-10 Albany Medical College Protein-lipid vesicles and autogenous vaccine comprising the same
US6180114B1 (en) 1996-11-21 2001-01-30 University Of Washington Therapeutic delivery using compounds self-assembled into high axial ratio microstructures
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
NO20002828D0 (no) * 2000-06-02 2000-06-02 Statens Inst For Folkehelse Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav
GB0103170D0 (en) * 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition

Also Published As

Publication number Publication date
EP2347764A2 (de) 2011-07-27
EP2347764A3 (de) 2011-10-26
ZA200504729B (en) 2006-09-27
EP1602360A1 (de) 2005-12-07
DK1602360T3 (da) 2012-02-13
CU23313A1 (es) 2008-09-25
BR0316687A (pt) 2005-10-18
CN1744883A (zh) 2006-03-08
ES2376227T3 (es) 2012-03-12
EP1602360B1 (de) 2011-10-26
HK1088827A1 (en) 2006-11-17
AR042237A1 (es) 2005-06-15
CA2518906A1 (en) 2004-06-10
CN1744883B (zh) 2011-06-08
US20060134134A1 (en) 2006-06-22
WO2004047805A1 (es) 2004-06-10
AU2003281911A1 (en) 2004-06-18

Similar Documents

Publication Publication Date Title
DE60307794D1 (de) Verfahren zum Verpacken, Packmittel und dessen Herstellungsverfahren
DE60315450D1 (de) Polymerzusammensetzungen und verfahren zum herstellen von rohren daraus
ATE347213T1 (de) System und verfahren zum integrieren von wlan und 3g
DE602004016923D1 (de) Gleitelement und Verfahren zum Herstellen des Gleitelements
DE60304002D1 (de) Automatisiertes System und Verfahren zum Herstellen von hochviskosen Flüssigkeitsrezepturen
DE60321566D1 (de) Verfahren und Dichtmittel zum Verbinden
ATA8612001A (de) Verfahren zum testen von software
DE60326760D1 (de) Verfahren zum verbinden
DE602004004267D1 (de) Formtrennmittelzusammensetzung und verfahren damit
DE50312932D1 (de) Verfahren und schaltungsanordnung zum begrenzen einer überspannung
DE602005004280D1 (de) Verfahren zum ziehen von sic-einkristallen und sic-einkristall
DE602004001399D1 (de) Verfahren zum herstellen von gleichmässig verteiltem material
DE60311286D1 (de) Vorrichtung und verfahren zum herstellen von hüllenlosen würsten
DE60336039D1 (de) Verstellbares Bohrgerät und assoziiertes Verfahren
DE60204101D1 (de) Knetvorrichtung und Verfahren zum Kneten von Zusammensetzungen auf Kautschukbasis
DE502004008042D1 (de) Verfahren zum umformen von blechen
DE60206601D1 (de) Verfahren und gerät zum aufnehmen, manipulieren und bewegen von produkten
EP1509252A4 (de) Verfahren und zusammensetzungen zur korrektur von herzüberleitungsstörungen
DE602004022156D1 (de) Verfahren zum verbinden von strickwaren
DE102004025103A8 (de) Verfahren und Einheit zum Verpacken von Gruppen von Produkten
DE60316234D1 (de) Verfahren zum Schutz von Artikeln, und entsprechende Zusammensetzungen
ATE530166T1 (de) Verfahren zum erhalt von kochleär-strukturen, impfzusammensetzungen, hilfsmittel und zwischenprodukte davon
DE602005017311D1 (de) Form und verfahren zum formen von produkten
DE50306401D1 (de) Verfahren und vorrichtung zum dauerhaften verbinden von einander überlappenden, plattenförmigen bauteilen
EP1778878A4 (de) Verfahren und zusammensetzungen zum nachweis von rhinoviren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1602360

Country of ref document: EP